Bayer Glyphosate Tariff Petition Draws Sharp Farm Group Backlash
Monsanto/Ruveon filing alleges unfair Chinese pricing, but corn and wheat groups warn duties would raise costs on one of farmers’ most widely used crop protection tools
Bayer’s Monsanto Company and wholly owned subsidiary Ruveon LLC filed a petition (link) seeking antidumping and countervailing duties on glyphosate from China, putting another major crop input into the trade-remedy spotlight. The attached public petition identifies the filing as an AD/CVD case before Commerce and the ITC, while Volume II focuses on the antidumping claim that Chinese glyphosate is being sold, or offered for sale, in the U.S. at less than fair value.
The petition’s core argument is that Chinese-produced glyphosate salts and glyphosate technical are imported into the U.S., then converted by U.S. formulators into generic herbicide products sold through distributors and retailers to farmers. The petition says there is no other significant U.S. market for those imported salts and technical material beyond herbicide formulation, and that generic Chinese-based formulations compete directly with U.S.-produced glyphosate formulations.
The public version shows the petitioners using October 2025 through March 2026 import data under HTS 2931.49.00.20 to calculate a Chinese glyphosate salt average unit value of $2.201 per kilogram, based on $136.9 million in customs value and 62.2 million kilograms of imports. The petitioners allege dumping margins for Chinese IPA salts ranging from 68.90% to 446.47%, though those are petition allegations, not final agency determinations.
That is where the legal case runs into the farm economy problem. Glyphosate is not a niche chemical; it is a basic weed-control tool across corn, soybean, wheat, fallow and no-till systems. Duties aimed at Chinese imports would land first in the import and formulation chain, but farm groups argue they would ultimately be passed through to growers in higher product prices or reduced generic competition. The risk is especially sensitive because farmers are already dealing with weak commodity prices, elevated financing costs and a string of disputes over fertilizer and crop-chemical trade barriers.
NCGA sharply criticized the move, saying glyphosate is one of the most used herbicides in corn production and that the petition is “highly concerning” for corn farmers. NCGA President Jed Bower said agricultural companies often position themselves as farmer partners, but “this is no act of partnership,” arguing the action benefits the company and shareholders “at the expense of the American farmer.” NCGA framed Bayer’s petition as part of a broader pattern that includes phosphate fertilizer duties sought by Mosaic and J.R. Simplot and Corteva’s 2,4-D trade case, warning that input companies are using trade remedy laws to limit competition in already concentrated markets.
NAWG took a similar position, with CEO Sam Kieffer saying wheat farmers “cannot predict the future” but know that tariffs on Russian and Moroccan phosphates cost wheat growers $1 billion in additional and unnecessary fertilizer expenses over five years. NAWG said glyphosate tariffs would be felt by farmers already facing high input costs, weak prices and market uncertainty, and urged the ITC to consider the impact on farmers, rural economies and the U.S. food system.
The political tension is that farm groups have been strong defenders of glyphosate access in regulatory and litigation fights, including Monsanto v. Durnell, where the Supreme Court recently sided with Bayer on pesticide-labeling preemption. But their message now is that access is not only about keeping the product legal; it is also about keeping it affordable and competitively supplied.
For Bayer, the petition fits a domestic-manufacturing and fair-trade argument: if Chinese glyphosate is being dumped or subsidized, duties would offset unfair pricing and help preserve U.S. production.
For growers, the concern is more immediate: another input-sector trade case could tighten supply options and give domestic suppliers more pricing power. The strongest farm-group argument is that trade remedies may protect one domestic producer while imposing broader costs on thousands of farmers who have no practical substitute for glyphosate in many production systems.
The next phase will determine whether the case gains traction at the ITC and Commerce. If the investigations move forward, growers and their associations are likely to press the argument that downstream farmer costs should matter. Their challenge is that AD/CVD law is built around domestic industry injury and unfair pricing or subsidies, not around whether farmers can absorb higher input costs. That legal mismatch is why farm groups are responding so forcefully at the start rather than waiting for duties to become a cash-market reality.
